Showing results (411-420 of 5,165) with videos related to

Sort By:
Pageof 517
Current Oncology (Toronto, Ont.)|June 20, 2015
Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experienceE Baxter, L Gondara, C Lohrisch, et al.
Current Oncology (Toronto, Ont.)|June 20, 2015
Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting-a pilot studyE Wong, N Pulenzas, G Bedard, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemicS F Roy, F M Ghazawi, M Le, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
The most important attribute: stakeholder perspectives on what matters most in a physicianP Wheatley-Price, K Laurie, T Zhang, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Impact of Recurrence Score on type and duration of chemotherapy in breast cancerK Willemsma, W Yip, N LeVasseur, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Digital gene expression analysis might aid in the diagnosis of thyroid cancerH Armanious, B Adam, D Meunier, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
How is best supportive care provided in clinical trials for patients with advanced cancer? A review of registered protocols of clinical trialsÁ Sanz Rubiales, M E Sánchez-Gutiérrez, L A Flores Pérez, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Canadian consensus: a new systemic treatment algorithm for advanced EGFR-mutated non-small-cell lung cancerB Melosky, S Banerji, N Blais, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancerM Aronson, C Swallow, A Govindarajan, et al.
Pageof 517